These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8262633)

  • 1. Biochemical analysis of the membrane and soluble forms of the complement regulatory protein of Trypanosoma cruzi.
    Norris KA; Schrimpf JE
    Infect Immun; 1994 Jan; 62(1):236-43. PubMed ID: 8262633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-binding renders the 160 kDa Trypanosoma cruzi complement regulatory protein susceptible to proteolytic cleavage.
    Norris KA
    Microb Pathog; 1996 Oct; 21(4):235-48. PubMed ID: 8905613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor.
    Norris KA; Bradt B; Cooper NR; So M
    J Immunol; 1991 Oct; 147(7):2240-7. PubMed ID: 1717552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance.
    Norris KA
    Infect Immun; 1998 Jun; 66(6):2460-5. PubMed ID: 9596703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the gene family encoding the 160-kilodalton Trypanosoma cruzi complement regulatory protein.
    Norris KA; Schrimpf JE; Szabo MJ
    Infect Immun; 1997 Feb; 65(2):349-57. PubMed ID: 9009282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway.
    Fischer E; Ouaissi MA; Velge P; Cornette J; Kazatchkine MD
    Immunology; 1988 Oct; 65(2):299-303. PubMed ID: 2973433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF.
    Tambourgi DV; Kipnis TL; da Silva WD; Joiner KA; Sher A; Heath S; Hall BF; Ogden GB
    Infect Immun; 1993 Sep; 61(9):3656-63. PubMed ID: 7689538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
    Joiner K; Sher A; Gaither T; Hammer C
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6593-7. PubMed ID: 2944112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-Based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection.
    Sepulveda P; Hontebeyrie M; Liegeard P; Mascilli A; Norris KA
    Infect Immun; 2000 Sep; 68(9):4986-91. PubMed ID: 10948115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate.
    Sher A; Hieny S; Joiner K
    J Immunol; 1986 Nov; 137(9):2961-7. PubMed ID: 3531342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and purification of functional, recombinant Trypanosoma cruzi complement regulatory protein.
    Beucher M; Meira WS; Zegarra V; Galvão LM; Chiari E; Norris KA
    Protein Expr Purif; 2003 Jan; 27(1):19-26. PubMed ID: 12509980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.
    Barilla-LaBarca ML; Liszewski MK; Lambris JD; Hourcade D; Atkinson JP
    J Immunol; 2002 Jun; 168(12):6298-304. PubMed ID: 12055245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of resistance to lysis by the alternative complement pathway in Trypanosoma cruzi trypomastigotes: effect of specific monoclonal antibody.
    Schenkman S; Güther ML; Yoshida N
    J Immunol; 1986 Sep; 137(5):1623-8. PubMed ID: 2943798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence diversity of the Trypanosoma cruzi complement regulatory protein family.
    Beucher M; Norris KA
    Infect Immun; 2008 Feb; 76(2):750-8. PubMed ID: 18070905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanism of activation of the alternative complement pathway by the classical pathway: protection of C3b from inactivation by covalent attachment to C4b.
    Meri S; Pangburn MK
    Eur J Immunol; 1990 Dec; 20(12):2555-61. PubMed ID: 2148521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis.
    Fukui A; Yuasa-Nakagawa T; Murakami Y; Funami K; Kishi N; Matsuda T; Fujita T; Seya T; Nagasawa S
    J Biochem; 2002 Nov; 132(5):719-28. PubMed ID: 12417021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi: the Tc-85 surface glycoprotein shed by trypomastigotes bears a modified glycosylphosphatidylinositol anchor.
    Abuin G; Couto AS; de Lederkremer RM; Casal OL; Galli C; Colli W; Alves MJ
    Exp Parasitol; 1996 Apr; 82(3):290-7. PubMed ID: 8631380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b.
    Kozono H; Kinoshita T; Kim YU; Takata-Kozono Y; Tsunasawa S; Sakiyama F; Takeda J; Hong K; Inoue K
    J Biol Chem; 1990 Aug; 265(24):14444-9. PubMed ID: 2387864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
    Kinoshita T; Dodds AW; Law SK; Inoue K
    Biochem J; 1989 Aug; 261(3):743-8. PubMed ID: 2803239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies.
    Norris KA; Harth G; So M
    Infect Immun; 1989 Aug; 57(8):2372-7. PubMed ID: 2663722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.